Antirapsyn antibodies occur commonly in patients with lupus

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 525-526

  Agius, Mark A ^a   Zhu, Shan ^a   Aarli, Johan A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; AUTOANTIBODY; CHOLINERGIC RECEPTOR; PROCAINAMIDE; RAPSYN; RECEPTOR SUBUNIT;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; HUMAN; LUPUS ERYTHEMATOSUS; MYOPATHY; NEUROMUSCULAR SYNAPSE; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR DENSITY;

EID: 0031903237     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10974.x     Document Type: Conference Paper

References (2)

1. BLAIR, D. A., M. MIHOVILOVIC, M. A. AGIUS, R. H. FAIRCLOUGH & D. P. RICHMAN. 1987. Human × human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia. Ann. N.Y. Acad. Sci. 505: 155-166.
2. ZHU, S., R. H. FAIRCLOUGH & M. A. AGIUS. 1996. Anti-rapsyn antibodies may contribute to pathogenicity in myasthenia gravis. FASEB J. 10: 4163.